Imunon
IMNN
20 hedge funds and large institutions have $3.27M invested in Imunon in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
30% more capital invested
Capital invested by funds: $2.52M → $3.27M (+$744K)
5% more funds holding
Funds holding: 19 → 20 (+1)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
35% less call options, than puts
Call options by funds: $99K | Put options by funds: $152K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$605K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$133K |
| 3 |
VF
Virtu Financial
New York
|
+$56.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$39.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$36.4K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$7.71K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$6.06K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$1.65K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$1K |
IMNN Hedge Fund Activity: Q3 2018 in Review
20 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2018, worth a combined $3.27M — up 30% from $2.52M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IMNN positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $605K. The largest seller was Morgan Stanley, cutting an estimated $36.4K.
- 20 institutional investors held Imunon (IMNN) as of Q3 2018, up from 19 in Q2 2018.
- Funds reported $3.27M of Imunon stock for Q3 2018, up 30% quarter-over-quarter.
- 4 funds opened new Imunon positions in Q3 2018 and 3 closed out, a net change of +1 holder.
- The largest Imunon buyer in Q3 2018 was Vanguard Group, an estimated $605K added.
- The largest Imunon seller in Q3 2018 was Morgan Stanley, an estimated $36.4K sold.
Based on aggregated 13F filings for Q3 2018.